Skip to content
Open access

May Measurement Month 2023: an analysis of blood pressure screening results from Oman

Jul 2026 · European Heart Journal, Supplement · 0 citations

TL;DR

The MMM campaign in Oman identified a substantial number of participants with untreated or inadequately treated hypertension, highlighting the need for broader community screening, targeted educational initiatives, and system-level strategies to improve hypertension control and reduce cardiovascular risk.

Abstract

The May Measurement Month (MMM) campaign was conducted in Oman in 2023 to raise awareness of raised blood pressure (BP). Adults aged ≥18 years were recruited through convenience sampling at hospitals, clinics, workplaces, and public spaces in eight regions of Oman. Three seated BP readings were taken on each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90mmHg or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. Multiple imputation was used to estimate missing BP readings. In total, 3,114 were screened, with a mean age of 40.1 years and 38.4% of whom were female. Of all participants, 1,010 (32.4%) had hypertension, of whom 421 (41.7%) were aware, and 389 (38.5%) were on antihypertensive medication. Of those on antihypertensive medication, 221 (56.8%) had controlled BP, and of all participants with hypertension, 21.9% had controlled BP. The MMM campaign in Oman identified a substantial number of participants with untreated or inadequately treated hypertension. These findings highlight persistent gaps in the awareness, identification, and management of hypertension across Oman. The MMM campaigns emphasise the need for broader community screening, targeted educational initiatives, and system-level strategies to improve hypertension control and reduce cardiovascular risk.

Read PDF

Similar papers

Aug 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Egypt

The May Measurement Month (MMM) campaign was conducted in Egypt in 2023 to raise awareness of raised blood pressure (BP). Adults aged ≥18 years were recruited through convenience sampling at hospitals, workplaces, and public areas across Egypt. Three seated BP readings were taken on each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90mmHg or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. Multiple imputation was used to estimate missing BP readings. In total, 2,701 were screened, with a mean age of 41.9 years and 44.5% were female. Of all participants, 661 (24.5%) had hypertension, of whom 452 (68.4%) were aware, and 431 (65.2%) were on antihypertensive medication. Of those on antihypertensive medication, 290 (67.3%) had controlled BP, and of all participants with hypertension, 43.9% had controlled BP. Females had a higher prevalence of hypertension (27.3% vs 22.2%), awareness (75.9% vs 61.0%) and controlled BP (50.6% vs 37.2%) than males. The MMM campaign in Egypt identified a substantial number of participants with untreated or inadequately treated hypertension, underscoring a high burden and persistent gaps in detection and management. These findings highlight the need for public education, clinical management, and community-centric screening and interventions to improve BP control and reduce cardiovascular risk.

Marina Sous, Farah Bishay, Esraa Magdy et al. · 0 citations
Open access Jul 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Thailand

The May Measurement Month (MMM) campaign was conducted in Thailand in 2023 to raise awareness of raised blood pressure (BP). Adults aged ≥18 years were recruited through convenience sampling at voluntary healthcare centres throughout Thailand. Three seated BP readings were taken on each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90mmHg or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. Multiple imputation was used to estimate missing BP readings. In total, 14,390 were screened, with a mean age of 52.7 years and 60.2% were female. Of all participants, 6,377 (44.3%) had hypertension, of whom 5,137 (80.6%) were aware, and 5,066 (79.4%) were on antihypertensive medication. Of those on antihypertensive medication, 3,391 (66.9%) had controlled BP, and of all participants with hypertension, 53.2% had controlled BP. The MMM campaign in Thailand identified a substantial number of participants with untreated or inadequately treated hypertension. Strategies to deliver early and effective BP control must be emphasized.

Chavalit Chotruangnapa, S. Kunanon, P. Kotruchin et al. · 0 citations
Open access Aug 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Vietnam

The May Measurement Month (MMM) campaign was conducted in Vietnam in 2023 to raise awareness of raised blood pressure (BP). Adults aged ≥18 years were recruited through convenience sampling at multiple sites across various provinces and cities throughout Vietnam. Three seated BP readings were taken from each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90mmHg or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. Multiple imputation was used to estimate missing BP readings. In total, 10,944 adults were screened, with a mean age of 53.5 years and 52.3% were female. Of all participants, 4,905 (44.8%) had hypertension, of whom 3,673 (74.9%) were aware, and 3,584 (73.1%) were on antihypertensive medication. Of those on antihypertensive medication, 1,925 (53.7%) had controlled BP, and of all participants with hypertension, 39.2% had controlled BP. The MMM campaign in Vietnam identified a substantial number of participants with untreated or inadequately treated hypertension. These findings underscore the urgent need for strengthened national strategies to improve hypertension screening, treatment accessibility, and long-term blood pressure control.

M. Van, Viet Nguyen Lan, Son Tran Kim et al. · 0 citations
Open access Aug 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in the Philippines

The May Measurement Month (MMM) campaign was conducted in the Philippines in 2023 to raise awareness of the importance of raised blood pressure (BP). Adults aged ≥ 18 years were recruited via opportunistic/convenience sampling at various screening sites. Three seated BP readings were taken on each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg and/or diastolic BP ≥90mmHg or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. In total, 33,190 were screened, with a mean age of 45.6 years and 58.9% were female. Of all participants, 11,421 (34.4%) had hypertension, of whom 4,177 (36.6%) were aware, and 4,058 (35.5%) were on antihypertensive medication. Of those on antihypertensive medication, 2,088 (51.5%) had controlled BP, and of all participants with hypertension, 18.3% had controlled BP. The MMM campaign in the Philippines identified a substantial number of participants with untreated or inadequately treated hypertension. This group of patients represent a missed opportunity for prevention of complications, hence the need for improved awareness through establishment of year-round hypertension screening programs and the use of at least two or more first-line antihypertensive drugs to achieve good BP control as recommended by guidelines.

A. Mina, N. Poulter, T. Beaney et al. · 0 citations
Open access Aug 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Ghana

The May Measurement Month (MMM) campaign was conducted in Ghana in 2023 to raise awareness of raised blood pressure (BP). Adults aged ≥18 years were recruited through convenience sampling in the Greater Accra, Eastern, Central and Ashanti Regions of Ghana. Three seated BP readings were taken on each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90mmHg or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. In total, 4,203 were screened, with a mean age of 33.6 years and 29.0% were female. Of all participants, 506 (12.0%) had hypertension, of whom 73 (14.4%) were aware, and 69 (13.6%) were on antihypertensive medication. Of those on antihypertensive medication, 26 (37.7%) had controlled BP, and of all participants with hypertension, 5.1% had controlled BP. The MMM campaign in Ghana identified a substantial number of participants with untreated or inadequately treated hypertension. It is significant to note that the annual BP screening campaign is a means to create awareness of the need to get screened and also identify individuals with high BP.

Betty Owusu-Ansah, Joseph O Kiddy-Kodua, Martin Adu-Adadey et al. · 0 citations
Jul 2026

May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in United Arab Emirates

The May Measurement Month (MMM) campaign was conducted in United Arab Emirates (UAE) in 2023 to raise awareness of raised blood pressure (BP). Adults aged ≥18 years were recruited through convenience sampling at participated hospitals/clinics, chain of pharmacies and selected out-reach community events throughout the country. Three seated BP readings were taken on each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90mmHg or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. Multiple imputation was used to estimate missing BP readings. In total, 77,008 adults were screened, with a mean age of 37.8 years and 47.3% were female. Of all participants, 14,912 (19.4%) had hypertension, of whom 7,799 (52.3%) were aware, and 7,408 (49.7%) were on antihypertensive medication. Of those on antihypertensive medication, 4,222 (57.0%) had controlled BP, and of all participants with hypertension, 28.3% had controlled BP. Females showed better awareness and BP control than males. MMM23 highlights a substantial burden of hypertension in the UAE, with many individuals untreated or inadequately controlled. These findings reinforce the value of large-scale screening and the need for targeted public health strategies to improve hypertension detection, treatment, and control.

Buthaina A Bin Belaila, T. Beaney, G. Kerr et al. · 0 citations